MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$778K
Free Cash flow
$1,908K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Accounts payable
Stock-based compensation expense
Payment of principal related to ...
Reduction in the operating right...
Negative Cash Flow Breakdown
Deferred revenue
Accrued expenses
Payment of finance liability fro...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2025-09-30
2025-06-30
Net income (loss)
44,717
-19,040
Depreciation and amortization expense
0
661
Stock-based compensation expense
421
939
Reduction in the operating right of use assets
32
1,233
Write-off of deferred financing costs
0
208
Loss on sale of assets held for sale
320
-3,539
Gain (loss) on sale of property and equipment
0
113
Non-cash interest expense
0
31
Loss on abandonment of operating lease right-of-use asset
0
927
Gain on sale of sale-leaseback
0
-
Prepaid expenses and other assets
805
-3,328
Accounts payable
1,140
1,951
Accrued expenses
-1,438
-4,922
Deferred revenue
-41,250
-3,729
Operating lease liabilities
-589
-1,041
Other long term liabilities
0
57
Net cash used in operating activities
1,908
-15,971
Proceeds from sales of assets held for sale
0
163
Proceeds from sales of property and equipment
0
524
Purchases of property and equipment
0
0
Net cash provided by (used in) investing activities
0
687
Payment of principal related to finance lease liabilities
-60
304
Proceeds from failed sale-leaseback arrangement
0
0
Payment of finance liability from failed sale-leaseback arrangements
1,190
327
Proceeds from the exercise of stock options
0
5
Sale of common stock under open market sale agreement, net of issuance costs
0
0
Net cash (used in) provided by financing activities
-1,130
-626
Net decrease in cash, cash equivalents and restricted cash
778
-15,910
Cash and cash equivalents at beginning of period
17,909
-
Cash and cash equivalents at end of period
2,777
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net income (loss)
$44,717K
Accounts payable
$1,140K
Stock-based compensation
expense
$421K
Reduction in the operating
right of use assets
$32K
Net cash used in
operating activities
$1,908K
Canceled cashflow
$44,402K
Net decrease in
cash, cash...
$778K
Canceled cashflow
$1,130K
Deferred revenue
-$41,250K
Accrued expenses
-$1,438K
Prepaid expenses and
other assets
$805K
Operating lease
liabilities
-$589K
Loss on sale of assets
held for sale
$320K
Payment of principal
related to finance lease...
-$60K
Net cash (used in)
provided by financing...
-$1,130K
Canceled cashflow
$60K
Payment of finance
liability from failed...
$1,190K
Buy us a coffee
Carisma Therapeutics Inc. (CARM)
Carisma Therapeutics Inc. (CARM)